Grants

This grant incentivises the creation and development of Joint Cluster Initiatives (EUROCLUSTERS) under the Single Market Programme to improve the resilience of European industrial ecosystems, boosting their green and digital transformation. The action supports clusters and SME members by fostering cross-sectorial and trans-European collaboration, with the aim of enhancing innovation, resilience of supply chains, and upskilling. Priorities include implementing the EU Green Deal industrial plan, REPowerEU plan, and promoting sustainable, circular solutions and diversification of production inputs.

This grant aims to reduce pollution from litter, plastics, and microplastics in European rivers by accelerating the uptake of innovative solutions and effective monitoring, contributing to the implementation of the Water Framework and Marine Strategy Framework Directives. Projects must aim for at least a 50% reduction of plastic litter at sea and at least 30% reduction of microplastics released into the environment, while contributing to digital ocean and water knowledge systems. Solutions may include upstream prevention, development of less polluting substitutes, and technologies to remove pollutants from rivers. At least five innovative solutions must be tested, with two focusing on eliminating microplastics. The initiative engages at least five 'associated regions' to scale innovation and build capacity for waste-free rivers, providing technical assistance and financial support up to EUR 100,000 per region.

This grant aims to fund pre-competitive research and innovation for novel tools, methods, and technologies to foster the development of health innovations that efficiently prevent, intercept, diagnose, treat, and manage diseases. The focus is on harnessing science and technologies that exploit digitalisation and data exchange, facilitating wider availability of interoperable, quality data in healthcare, promoting the use of advanced analytics and AI, supporting better clinical decision-making and shorter times to market, and contributing to European health research and innovation leadership. Actions under this topic will contribute to a range of EU priorities, strengthen competitiveness in the EU health industry, and enable delivery of patient-centric, people-centred, cost-effective and affordable health solutions.

This grant supports pre-competitive research and innovation for novel tools, methods, and technologies to foster the development of health innovations that prevent, intercept, diagnose, treat, and manage diseases and to enable efficient recovery. Projects should break down fragmentation in medicine and technology by developing integrated, people-centred healthcare solutions. The grant aims for increased competitiveness of the EU’s health industry, sustainable biotechnology innovation, digital health transformation, and contributes to strategic EU initiatives such as the European Green Deal, Beating Cancer Plan, Virtual Human Twins Initiative, and more. Proposals must deliver outcomes that address public health needs, support future health innovations that are safe, effective, affordable, and people-centred, and benefit all stakeholders in healthcare.

Funding for collaborative pre-competitive research to develop new tools, methods, and technologies for the comprehensive assessment of the added value of innovative and integrated healthcare solutions. Targeted outcomes include strengthening the EU health industry, promoting patient access to innovation, improving health technology assessment methodologies, and ensuring efficient integration of digital and regulatory solutions into healthcare.

This grant aims to fund pre-competitive research and innovation for novel tools, methods, and technologies to foster the development of people-centred, integrated healthcare solutions. The goal is to support innovations that help prevent, intercept, diagnose, treat, and manage diseases more efficiently, facilitating recovery, and to address public health needs. Actions funded will advance implementation of integrated healthcare solutions (including digital ones), promote collaboration among healthcare stakeholders (patients, citizens, industry), and foster safer, more effective, affordable, and sustainable health innovations. The initiative targets strengthening the EU health industry's competitiveness and aligns with EU strategies and policies (e.g., European Green Deal, Cancer Mission, AI Strategy, European Health Data Space).

This grant aims to fund pre-competitive research and innovation into novel tools, methods, and technologies to foster health innovations that improve the prevention, interception, diagnosis, treatment, and management of diseases, contributing to a better understanding of the determinants of health. Projects are expected to deliver people-centred, effective, and affordable innovations and to strengthen the EU’s health industry competitiveness and technological leadership in line with the IHI JU Strategic Research and Innovation Agenda. Applications should be collaborative, cross-sectoral partnerships focused on unmet public health needs, translation of research into innovative solutions, and synergies with existing initiatives. Topics include digitalisation, artificial intelligence, greener and more sustainable healthcare, and deployment of innovative health technologies.

This call aims to contribute to the promotion of social dialogue at the cross-industry and sectoral level, developing European social dialogue, and building and strengthening the capacity of social partner organisations in both Member States and candidate countries. Expected results include increased awareness and enhancement of European social dialogue, and improved capacity of social partners, ultimately leading to a strengthened EU-level social dialogue.

This grant supports the establishment of training, twinning, and innovation networks to build and sustain workforce capacity in ethics, regulatory, and pharmacovigilance (PV) in sub-Saharan Africa (SSA). It focuses on addressing gaps in regulatory oversight, ethics review committees, and PV systems for medical products (therapeutics and vaccines) by leveraging digital technologies, including AI and big data. The overall aim is to harmonise standards and strengthen digital regulatory platforms, contributing to resilient and future-ready health regulation and strengthened research ethics and PV environments across SSA.